Global B2B Pharmaceutical Sourcing Β· Dossier Licensing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Arthritis β€” Manufacturers, Suppliers & Exporters

Can't find the Arthritis product you need?
Send us an RFP β€” our team sources it from verified manufacturers and reverts with quotes.
Send RFP β†’

Browse Arthritis products

D-PENICILLAMINE

Strength: 250 mg

Form: Capsules

Reference Brands: Cuprimine, Depen (US)

View Details Get Enquiry

Dexamethasone tablets

Strength: 0.5 mg, 0.75 mg, 1 mg, 2 mg, 4 mg, 6 mg

Form: Oral Tablets

Reference Brands: Decadron(US & EU)

View Details Get Enquiry

Diacerein Capsules

Strength: 50 mg

Form: Capsules

Reference Brands: Art 50 (EU)

View Details Get Enquiry

Diacerein, Glucosamine Sulphate & Methyl sulfonyl methane Tablets

Strength: 10 Tab

Form: Tablets

Reference Brands: Dona (EU)

View Details Get Enquiry

Diclofenac Sodium 25 mg tablets

Strength: 25 mg, 50 mg, 75 mg, 100 mg

Form: Tablets

Reference Brands: Voltaren(US), Voltarol (EU)

View Details Get Enquiry

Diclofenac Extended-Release Tablets

Strength: 100 mg

Form: Extended-Release Tablets

Reference Brands: Voltaren(US & EU), Voveran SR (India)

View Details Get Enquiry

Diclofenac Injectable

Strength: 75 mg/3 mL (Vial)

Form: Injection

Reference Brands: Voltaren(US & EU)

View Details Get Enquiry

Diclofenac Topical Gel

Strength: 1%, 2%, 4%

Form: Topical Gel

Reference Brands: Voltaren(US & EU), Voveran Gel (India), DicloGel (India)

View Details Get Enquiry

Etanercept Pen

Strength: 50 mg/0.5 mL, 50 mg/1 mL

Form: Pre-filled Syringe or Pen

Reference Brands: Enbrel (US & EU)

View Details Get Enquiry

Etoricoxib tablets

Strength: 60 mg, 90 mg, 120 mg

Form: Tablets

Reference Brands: Arcoxia (EU)

View Details Get Enquiry

Febuxostat tablets

Strength: 40 mg, 80 mg

Form: Oral Tablets

Reference Brands: Uloric(EU & US)

View Details Get Enquiry

Filgotinib tablets

Strength: 100 mg, 200 mg

Form: Tablets

Reference Brands: Jyseleca(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.